GEHC
vs
S&P 500
GEHC
S&P 500
Over the past 12 months, GEHC has underperformed S&P 500, delivering a return of +6% compared to the S&P 500's +14% growth.
Stocks Performance
GEHC vs S&P 500
Performance Gap
GEHC vs S&P 500
Performance By Year
GEHC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
GE Healthcare Technologies Inc
Glance View
GE Healthcare Technologies Inc. operates as a pivotal player in the vast landscape of medical technology, skillfully weaving a narrative that integrates cutting-edge innovation with practical application. As a segment originally spun out from the iconic General Electric Company, GE Healthcare focuses on enhancing diagnostics and patient care through its advanced imaging and monitoring systems. The company's portfolio spans a wide range of products, including magnetic resonance imaging (MRI) machines, ultrasound devices, and computed tomography (CT) scanners, each designed to provide medical professionals with critical insights needed for accurate diagnosis and effective treatment. By leveraging decades of engineering expertise and a rich history in innovation, GE Healthcare not only improves hospital efficiencies but also supports personalized healthcare solutions that help in the early detection and effective management of diseases. Their revenue model is primarily centered around the sale of these high-technology machines and the accompanying service agreements that ensure their seamless operation. Additionally, the company generates income from its work in life sciences, offering a suite of applications and software that assist in drug discovery and bioprocessing. Combining hardware sales with recurring revenue streams from maintenance services and digital solutions enhances the company’s financial stability. This multifaceted approach positions GE Healthcare as both a stalwart in existing medical technology fields and a pioneer exploring the frontiers of healthcare innovations, driven by a mission to improve patient outcomes worldwide.
